Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Oxaliplatin 64 pembrolizumab 48 Fluorouracil 44 Capecitabine 38 Nivolumab 33 Leucovorin 32 Paclitaxel 28 Trastuzumab 19 Docetaxel 18 Cisplatin 18 S 1 (combination) 16 Bevacizumab 15 Ramucirumab 13 Irinotecan 13 Drug Therapy 13 tislelizumab 12 Cyclophosphamide 12 fludarabine 10 Carboplatin 10 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 trastuzumab deruxtecan 8 sintilimab 8 Specimen Handling 8 Biopsy 8 atezolizumab 7 Surgical Procedures, Operative 7 Gemcitabine 7 zolbetuximab 6 durvalumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Simethicone × 1 year × Clear all

NCT07245095 2025-11-24

NACSIMET

Hospital General de Mexicali

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡